Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary Colonoscopies

NACompletedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

May 25, 2020

Primary Completion Date

January 5, 2022

Study Completion Date

July 5, 2022

Conditions
Colorectal CancerPolyp of ColonColorectal Neoplasms
Interventions
DEVICE

AeonoseTM

All participants will be asked to breathe into an electronic nose (eNose, the AeonoseTM, The eNose Company, Zutphen, the Netherlands) for 5 minutes during the pre-colonoscopy intake and just prior to the procedure to assess reproducibility (with \>2 weeks in between).

Trial Locations (1)

6525GA

Radboud university medical center, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT04357158 - Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary Colonoscopies | Biotech Hunter | Biotech Hunter